产品封面图

RBL-2H3

收藏
  • 询价
  • 2025年10月12日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 生长状态

      贴壁生长

    • 器官来源

      外周血

    • 相关疾病

      其他疾病

    • ATCC Number

      CRL-2256™

    • 品系

      Wistar

    • 运输方式

      冻存运输

    • 细胞形态

      成纤维样

    • 库存

      大量

    • 物种来源

      大鼠

    • 是否是肿瘤细胞

      0

    • 细胞类型

      其他细胞类型

    Designations: RBL-2H3
    Depositors:  RP Siraganian
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Rattus norvegicus deposited as Rattus sp.
    Morphology: fibroblast

    Source: Strain: Wistar
    Organ: peripheral blood
    Disease: basophilic leukemia
    Cell Type: basophil; chemically induced
    Cellular Products: histamine
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    Receptors: FcERI (Fc of IgE)
    Comments: RBL-2H3 is a basophilic leukemia cell line isolated and cloned in 1978 in the Laboratory of Immunology at the National Institute of Dental Research from Wistar rat basophilic cells that were maintained as tumors.
    These cells have high affinity IgE receptors.
    They can be activated to secrete histamine and other mediators by aggregation of these receptors or with calcium ionophores.
    They have been used extensively to study FcERI and the biochemical pathways for secretion in mast cells.
    RBL-2H3 cells have been the model for studies of structure of FcERI.
    They have been used extensively for studies of different aspects of secretion in cells including the role of changes in intracellular calcium, the activation of phospholipases, protein kinases and small G proteins.
    Although nearly all lots of fetal bovine serum support the growth of these cells, the cells grown in some lots degranulate better after FcERI aggregation.
    Another rat basophil line is available (RBL-1, see ATCC CRL-1378 ) that does not degranulate.
    Histamine release capacity may be seriously reduced after too much subculturing. PubMed: 6166481.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: heat-inactivated fetal bovine serum to a final concentration of 15%.
    Temperature: 37.0°C
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

        Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:8 is recommended
        Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5%
    Storage temperature: liquid nitrogen vapor temperature
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
    References: 1232: Kulczycki A Jr., et al. The interaction of IgE with rat basophilic leukemia cells. I. Evidence for specific binding of IgE. J. Exp. Med. 139: 600-616, 1974. PubMed: 4812630
    22475: Barsumian EL, et al. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol. 11: 317-323, 1981. PubMed: 6166481
    22638: Eccleston E, et al. Basophilic leukaemia in the albino rat and a demonstration of the basopoietin. Nat. New Biol. 244: 73-76, 1973.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 目前已发表文章中RNAi设计的片段综述

      Bruton's tyrosine kinase (Btk) (33) NM_000061 1682-1700 AAUUGGUAAACGAUCAAGGAG RBL-2H3, WEHI-231, NALM

    • 【交流】目前已发表文章中RNAi设计的片段综述

      , hematopoetic cells beta-tubulin- mouse neuronal (21) AF312873 AAGACAGAGCCAAGUGGACUC Mouse P19 Bruton's tyrosine kinase (Btk) (33) NM_000061 1682-1700 AAUUGGUAAACGAUCAAGGAG RBL-2H3, WEHI-231, NALM-6 Bruton's tyrosine kinase (Btk) (33) NM_000061 895-913

    • 如何选用免疫缺陷小鼠,这篇文章告诉你诀窍

      后 6 周仍然维持较高水平重建。 图 5:植入人外周血中 NK 细胞后 B-NDG hIL-15 小鼠中重建 NK 细胞的数量和比例[5] B-NDG 小鼠在 PDX 中的应用 2022 年 Cancer Letters 中使用 B-NDG 小鼠胰腺癌 PDX 模型,证明了 HOXB9 通过上调 RBL2 和抑制 c-Myc 阻断 G0/G1 期的细胞周期进程,DNMT1 使得 HOXB9 甲基化并下调其表达。 图 6:Cancer Lett.2022;533

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1480
    上海酶研生物科技有限公司
    2026年01月16日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月13日询价
    ¥1280
    上海康朗生物科技有限公司
    2025年07月06日询价
    ¥1320
    博辉生物科技(广州)有限公司
    2025年12月25日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月09日询价
    RBL-2H3
    询价